Email this article 
Allergic contact dermatitis
- Authors: Kochergin NG1
-
Affiliations:
- First Moscow State Medical University
- Issue: Vol 11, No 1 (2014)
- Pages: 73-79
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.12.2014
- URL: https://rusalljournal.ru/raj/article/view/573
- DOI: https://doi.org/10.36691/RJA573
- ID: 573
Cite item
Open Access
Access granted
Abstract
Russian Dermatology describes irritant and allergic contact dermatitis. The latter one being immune associated is characterized by huge spectrum of clinical features demanding individual approaches to topical corticosteroid therapy. Hydrocortizone 17-butirate in the formulations of ointment, cream, Lipocream and Crelo allows effectively and safely solve therapeutic problems of topical treatment.
Full Text
References
- Кожные и венерические болезни. Под ред. О.Л. Иванова. М., «Шико». 2006, 226 с.
- Кочергин Н.Г., Петрунин Д.Д. Современный взгляд на проблему выбора лекарственной формы средств наружной терапии. Клин. дерматол. венерол. 2011, № 6, с. 78-85.
- Gip L., Verjans H.L. Hydrocortisone 17-butyrate 0,1% Lipocream vs betamethasone 17-valerate 0.1% cream in the treatment of patients with dry severe chronic eczema. Curr. Ther. Res. 1987, v. 41, p. 258-264.
- Guillet G., Nougue J. Etude comparative en double aveugle de deux dermocorticoides dans l’eczema aigu ou chronique 17-butyrate d’hydrocortisone crème epaisse versus dipropionate d’betamethasone pomade. Ther. Pharmacol. Clin. 1989, v. 7 (79), p. 10-17.
- Letawe C., Pierard-Franchimont C,. Pierard G.E. Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur. J. Clin. Pharmacol. 1996, v. 51, p. 253-257.
- Fowler J.F., Fransway A.F., Jackson J.M., Rohowsky N. Hydrocortisone butyrate 0,1% cream in the treatment of chronic dermatitis. Cutis. 2005, v. 75, p. 125-131.
- Berbis P., Hesse S., Privat Y. Essential fatty acids and the skin. Allerg. Immunol. 1990, v. 22 (6), p. 225-231.
- Niedner R., Degen A. Lokaltherapie der Psoriasis capilliti mit einer Hydrocortison-17- Butyrat-Emulsion im Vergleich zu einer Betamethason-17-Valerat-Lotion. Dtsch. Dermatol. 1993, v. 2, p. 198-200.
- Pierard G.E., Lachapelle J.M., Frentz G. et al. Hydrocortisone 17-butyrate topical emulsion (Locoid Crelo) in psoriasis. J. Eur. Acad. Dermatol. Venereol. 1996, v. 6, p.11-14.
- De Cuyper C., Degreef H.J., de la Brassinne M. et al. A randomized, single-blind study to compare hydrocortisone 17-butyrate 0,1% emulsion (HCB) versus betamethasone 17,21-dipropionate 0,05% lotion in the treatment of patients suffering from psoriasis of the scalp. J. Eur. Acad. Dermatol. Venerol. 1995. v. 5, Suppl. 1, p. 104-105.
- Jacoby H. A randomized, single-blind study to compare clinically and by squamometry the effect of Locoid (hydrocortisone 17-butyrate 0,1%) Crelo versus Diprosone (betamethasone 17,21-dipropionate 0,05%) lotion on the structure of stratum corneum in patients suffering from seborrhoeic dermatitis. Yamanouchi Doc. 1998, v. 701, p. 1-56.
Supplementary files
